Thursday, December 20, 2018

Targeted treatment slows progression of rare connective tissue tumor

A drug called sorafenib stopped progression of desmoid tumors for 80 percent of patients taking the drug over a two-year period as part of a phase 3 trial.

from Latest Science News -- ScienceDaily https://ift.tt/2LteupE
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

JWST spots a strange red dot so extreme scientists can’t explain it

The discovery of strange, ultra-red objects—especially the extreme case known as The Cliff—has pushed astronomers to propose an entirely new...